unknown
Stage
About
Anebulo Pharmaceuticals develops Selonabant, a drug candidate aimed at reversing acute cannabis-induced toxicities, particularly in children, addressing serious conditions like CNS and respiratory depression caused by unintentional cannabis exposure.
Explore Anebulo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.